Fructose-3 phosphate production and polyol pathway metabolism in diabetic rat hearts

Metabolism: Clinical and Experimental

Volumn 46, Issue 11, 1997, Pages 1333-1338

  Lal, Sundeep ^a   Randall, William C ^a   Taylor, Anne H ^a   Kappler, Francis ^a   Walker, Michael ^a   Brown, Truman R ^a   Szwergold, Benjamin S ^a,b  

^a FOX CHASE CANCER CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; FRUCTOSE; FRUCTOSE 3 PHOSPHATE; POLYOL; SORBITOL;

ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; GAS CHROMATOGRAPHY; GLYCATION; HEART FUNCTION; MALE; MASS SPECTROMETRY; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0030822416     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90240-7     Document Type: Article

References (51)

1. Hamby RI, Zoneraich S, Sherman S: Diabetic cardiomyopathy. JAMA 229:1749-1754, 1974
2. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: The Farmingham Study. Am J Cardiol 34:29-35, 1974
3. Schaffer SW: Cardiomyopathy associated with noninsulin-dependent diabetes. J Mol Cell Biochem 107:1-20, 1991
4. Cameron NE, Cotter MA, Robertson S: Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition. Diabetologia 32:365-370, 1989
5. Litwin SE, Raya TE, Anderson PG, et al: Abnormal cardiac function in the streptozotocin-diabetic rat. J Clin Invest 86:481-488, 1990
6. Fein FS, Sonnenbick EH: Diabetic cardiomyopathy. Prog Cardiovasc Dis 27:255-270, 1985
7. Regan TJ, Lyons MM, Ahmed SS, et al: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60:885-899, 1977
8. Sohar E, Ravid M, Ben-Shaul Y, et al: Diabetic fibrillosis. Am J Med 49:64-69, 1970
9. van Hoeven KH, Factor SM: A comparison of the pathological spectrum of hypertensive, diabetic and hypertensive-diabetic heart disease. Circulation 82:848-855, 1990
10. Avendano G, Agarwal R, Bashey R, et al: Role of TGF-β1 in the collagen accumulation of diabetic myocardium. J Invest Med 44:292, 1996 (abstr)
11. Spiro MJ, Crowley TJ: Increased rat myocardial type VI collagen in diabetes mellitus and hypertension. Diabetologia 36:93-98, 1993
12. Cotter MA, Cameron NE, Robertson S: Polyol pathway-mediated changes in cardiac muscle contractile properties: Studies in streptozotocin-diabetic and galactose-fed rats. Exp Physiol 77:829-838, 1992
13. Kashiwagi A, Obata T, Suzaki M, et al: Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats. Metabolism 41:1041-1046, 1992
14. Garvey WT, Hardin D, Juhaszova M, et al: Effects of diabetes on myocardial glucose transport system in rats: Implications for diabetic cardiomyopathy. Am J Physiol 264:H837-H844, 1993
15. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol 253:E202-E207, 1987
16. +-ATPaSe activity in diabetic rat heart. Am J Physiol 245:C241-C247, 1983
17. 2+ pump activity during diabetes mellitus. Am J Physiol 252:H540-H544, 1987
18. Garber DW, Neely JR: Decreased myocardial function and myosin ATPase in hearts from diabetic rats. Am J Physiol 244:H586-H591, 1983
19. Xiang H, McNeill JH: Protein kinase C activity is altered in diabetic rat hearts. Biophys Biochem Res Commun 187:703-710, 1992
20. Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27:169-179, 1995
21. Yue DK, Mclennan S, Turtle JR: Non-enzymatic glycosylation of tissue protein in diabetes in the rat. Diabetologia 24:377-381, 1983
22. Norton GR, Candy G, Woodiwiss AJ: Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocininduced diabetes mellitus in rats. Circulation 93:1905-1912, 1996
23. Kumari K, Sahib MK: Susceptibility of different rat tissues to non-enzymatic protein glycosylation in experimental diabetes. Ind J Exp Biol 31:194-195, 1993
24. Bucala R, Cerami A: Advanced glycosylation: Chemistry, biology and implications for diabetes and aging. Adv Pharmacol 23:1-34, 1992
25. Brownlee M: Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic complications, in Rifkin H, Porte D (eds): Diabetes Mellitus. New York, NY, Elsevier, 1990, pp 279-291
26. Brownlee M: Glycation and diabetic complications (Lilly Lecture, 1993). Diabetes 43:836-841, 1994
27. Araki N, Ueno N, Chakrabarti B, et al: Immunochemical evidence for the presence of advanced glycation endproducts in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214, 1992
28. Nakayama H, Mitsuhashi T, Kuwajima S, et al: Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes 42:345-350, 1993
29. Shikata K, Makino H, Sugimoto H, et al: Localization of advanced glycation endproducts in the kidney of experimental diabetic rats. J Diabetes Complications 9:269-271, 1995
30. Mitsuhashi T, Nakayama H, Itoh T, et al: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 42:826-832, 1993
31. Makita Z, Vlassara H, Rayfield E, et al: Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651-653, 1992
32. Szwergold BS, Kappler F, Brown TR: Identification of fructose 3-phosphate in the lens of diabetic rats. Science 247:451-454, 1990
33. Lal S, Szwergold BS, Taylor AH, et al: Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch Biochem Biophys 318:191-199, 1995
34. Petersen A, Szwergold BS, Kappler R, et al: Identification of sorbitol-3-phosphate and fructose-3-phosphate in normal and diabetic human erythrocytes. J Biol Chem 265:17424-17427, 1990
35. 31P NMR spectroscopy. J Biol Chem 268:7763-7767, 1993
36. Kinoshita JH: A thirty year journey in the polyol pathway. Exp Eye Res 50:567-573, 1990
37. Reinhard S, Oates PJ: Aldose reductase inhibitors: Recent developments. Prog Drug Res 40:99-161, 1993
38. Benfield P: Aldose reductase inhibitors and late complications of diabetes. Drags 32:43-55, 1986
39. Greene DA, Lattimer SA: Action of sorbinil in diabetic peripheral nerve. Diabetes 33:712-716, 1984
40. Stribling D, Mirrlees DJ, Harrison HE, et al: Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effect on diabetic complications in the rat. Metabolism 34:336-344, 1985
41. Thomas TP, Feldman EL, Nakamura J, et al: Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proc Natl Acad Sci USA 90:9712-9716, 1993
42. Yorek MA, Wiese TJ, Davidson EP, et al: Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Diabetes 42:1401-1406, 1993
43. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
44. Williamson JR, Chang K, Frangos M, et al: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1990
45. Roy TM, Broadstone VL, Peterson HR, et al: The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus. Diabetes Res Clin Pract 10:91-97, 1990
46. Madson A, Feather MS: An improved preparation of 3-deoxy-D-erythrohexose-2-ulose via the bis(benzoyl hydrozone) and some related constitutional studies. Carbohydr Res 94:183-191, 1981
47. Yamada H, Miyata S, Igaki N, et al: Increase in 3-deoxyglucosone levels in diabetic rat plasma. J Biol Chem 269:20275-20280, 1994
48. Knecht KJ, Feather MS, Baynes JW: Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: Evidence for intermediate stages of the Maillard reaction in vivo. Arch Biochem Biophys 294:130-137, 1992
49. Fujii E, Iwase H, Ishii-Karakasa I, et al: The presence of 2-keto-3-deoxygluconic acid and oxaldehyde dehydrogenase activity in human erythrocytes. Biochem Biophys Res Commun 210:852-857, 1995
50. Vaca G, Alonso R, Zuniga P, et al: Sorbitol dehydrogenase deficiency in several pig tissues: Potential implications for studies of experimental diabetes. Diabetologia 27:482-483, 1984
51. Crane RK: The substrate specificity of liver glucose-6-phosphatase. Biochim Biophys Acta 17:443-444, 1955